Among them, CD3EAP and LY6H are prognostic risk genes for patients with endometrial cancer (HR > 1, Table 1), while DMC1 and TLE2 are prognostic protective genes (HR < 1, Table 1). This evidence concerns the gene DMC1 and endometrial cancer.